Vol 11. Issue 20 / June 20, 2011

Study Shows Component of Common Supplement May Alleviate Fatty Liver Disease, Improve Insulin Sensitivity — The study suggests a new treatment for prediabetic patients.

Researchers Advance Study of Hepatitis C with New Model — The results facilitate drug and vaccine development.

Scientists Awarded $2.2 Million to Develop Treatment for Multi-Drug Addiction — The funding to the Bohn lab will support the development of therapeutics for treating substance abuse.

Bruce Beutler Wins Shaw Prize for Immune Discoveries

Phillip Dawson Awarded Max-Bergmann Medal for Work on Protein Engineering Tools

Eros Lazzerini Denchi Named Pew Scholar in the BioMedical Sciences

Tatiana Domitrovic Named Pew Latin American Fellow

Francisco Garcia Receives Carl Storm Award from Gordon Research Conferences

Scripps Research Captures First Place in Bike-to-Work Challenge

Led by Advances in Chemical Synthesis, Team Discovers that a Rare Natural Product Has Potent Pain-Killing Properties

New Class of Compounds Offers Great R&D Potential

Slideshow: Scripps Research Holds 19th Commencement

Researchers Show How Shifts in Temperature Prime Immune Response

Study Suggests Enzyme Crucial to DNA Replication May Provide Potent Anti-Cancer Drug Target

Scientists Develop Compound that Effectively Halts Progression of Multiple Sclerosise

Scientists Find E. Coli Enzyme Must Move to Function

Scientists Find Sensory Wiring for Smells Varies Among Individuals

Method Reveals New View of Human Nerve Cells, Opening Door to Potential Drug Targets

Scripps Research and MIT Scientists Discover Class of Potent Anti-Cancer Compounds



Team Sheds New Light on How Blood Clots Form
The findings from the Ruf lab could lead to novel ways to prevent heart attack and stroke.